期刊
JOURNAL OF NEUROIMMUNOLOGY
卷 157, 期 1-2, 页码 197-202出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.jneuroim.2004.08.029
关键词
HIV-associated dementia; apolipoprotein; aging
资金
- NCRR NIH HHS [G12RR/AI 03061, G12 RR003061-20, P20 RR11091, U54 RR014607-05, P20 RR011091-11] Funding Source: Medline
- NINDS NIH HHS [1U54NS43049, U54 NS043049-05] Funding Source: Medline
There are discrepant findings regarding the risk of HIV-associated dementia (HAD) relating to apolipoprotein E4, suggesting other factors may modulate risk. Furthermore, evidence suggests a changing phenotype of HAD in the era of highly active antiretroviral therapy (HAART), prompting a need to determine if new disease markers have emerged. In this analysis, APOE genotype was determined for 182 participants enrolled in the Hawaii Aging with HIV Cohort. After controlling for age and diabetes status, an independent risk of HAD relating to E4 was seen in older participants [OR=2.898 (1.031-8.244)] but not in younger participants [OR=0.373 (0.054-1.581)]. Several proposed mechanisms may underlie this association. Consideration of non-traditional risk factors for HAD in older HIV patients may yield new markers of disease in the era of HAART. (C) 2004 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据